CuroNZ's Grant

CuroNZ raised a round of funding on October 14, 2013. Investors include Multiple Sclerosis Society of New Zealand.

CuroNZ is a small Biotechnology start-up company with a drug patent portfolio covering the peptide family, Neural Regeneration Peptides (NRPs). The company plans to develop our drug to the end of pre…

Articles about CuroNZ's Grant: